Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Magee-Womens Research Institute, Pittsburgh, PA, United States.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.
Am J Clin Nutr. 2024 Feb;119(2):527-536. doi: 10.1016/j.ajcnut.2023.10.015. Epub 2023 Dec 29.
The Institute of Medicine pregnancy weight gain guidelines were developed without evidence linking high weight gain to maternal cardiometabolic disease and child obesity. The upper limit of current recommendations may be too high for the health of the pregnant individual and child.
The aim of this study was to identify the range of pregnancy weight gain for pregnancies within a normal body mass index (BMI) range that balances the risks of high and low weight gain by simultaneously considering 10 different health conditions.
We used data from an United States prospective cohort study of nulliparae followed until 2 to 7 y postpartum (N = 2344 participants with a normal BMI). Pregnancy weight gain z-score was the main exposure. The outcome was a composite consisting of the occurrence of ≥1 of 10 adverse health conditions that were weighted for their seriousness. We used multivariable Poisson regression to relate weight gain z-scores with the weighted composite outcome.
The lowest risk of the composite outcome was at a pregnancy weight gain z-score of -0.6 SD (standard deviation) (equivalent to 13.1 kg at 40 wk). The weight gain ranges associated with no more than 5%, 10%, and 20% increase in risks were -1.0 to -0.2 SD (11.2-15.3 kg), -1.4 to 0 SD (9.4-16.4 kg), and -2.0 to 0.4 SD (7.0-18.9 kg). When we used a lower threshold to define postpartum weight increase in the composite outcome (>5 kg compared with >10 kg), the ranges were 1.6 to -0.7 SD (8.9-12.6 kg), -2.2 to -0.3 SD (6.3-14.7 kg), and ≤0.2 SD (≤17.6 kg). Compared with the ranges of the current weight gain guidelines (-0.9 to -0.1 SD, 11.5-16 kg), the lower limits from our data tended to be lower while upper limits were similar or lower.
If replicated, our results suggest that policy makers should revisit the recommended pregnancy weight gain range for individuals within a normal BMI range.
医学研究所的孕期体重增加指南是在没有证据表明体重增加与产妇心血管代谢疾病和儿童肥胖有关的情况下制定的。目前建议的上限对于孕妇和儿童的健康来说可能过高。
本研究旨在确定在正常体重指数(BMI)范围内,平衡高体重增加和低体重增加风险的孕期体重增加范围,同时考虑 10 种不同的健康状况。
我们使用了美国一项前瞻性队列研究中 2344 名正常 BMI 的初产妇的数据,这些女性在产后 2 至 7 年内一直随访。孕期体重增加 z 分数是主要暴露因素。结果是一个由 10 种不同健康状况组成的复合结局,每种健康状况的发生都有一个权重,以反映其严重程度。我们使用多变量泊松回归来分析体重增加 z 分数与加权复合结局的关系。
复合结局风险最低的是孕期体重增加 z 分数为-0.6 标准差(相当于 40 周时 13.1 公斤)。与风险增加不超过 5%、10%和 20%相关的体重增加范围分别为-1.0 至-0.2 标准差(11.2-15.3 公斤)、-1.4 至 0 标准差(9.4-16.4 公斤)和-2.0 至 0.4 标准差(7.0-18.9 公斤)。当我们使用较低的阈值来定义复合结局中的产后体重增加(>5 公斤与>10 公斤)时,范围分别为 1.6 至-0.7 标准差(8.9-12.6 公斤)、-2.2 至-0.3 标准差(6.3-14.7 公斤)和≤0.2 标准差(≤17.6 公斤)。与目前体重增加指南的范围(-0.9 至-0.1 标准差,11.5-16 公斤)相比,我们的数据的下限往往较低,而上限相似或较低。
如果得到证实,我们的结果表明决策者应该重新审视正常 BMI 范围内个人的推荐孕期体重增加范围。